Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Albany Medical Center, Albany, New York